Oncology Economist Impact: World Cancer Series – pharmaphorum in atte... Taking a brief look back to pharmaphorum’s coverage of Day One of The Economist’s 8th Annual
Oncology Economist Impact: World Cancer Series – pharmaphorum in atte... To conclude pharmaphorum’s look back at day one of The Economist’s 8th Annual World Cancer Series congress in Brussels, Belgium, in November – where the foci were “innovation, equity, and e
News ESMO26: Neoadjuvant Enhertu fails in early breast cancer AstraZeneca and Daiichi Sankyo's Enhertu failed to show efficacy as neoadjuvant therapy for early-stage HER2-low breast cancer in the TALENT trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
